Henri Zhuri, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1069 Broadway, Saugus, MA 01906 Phone: 781-233-1450 |
Rekha Selvanaayagam, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1069 Broadway, Saugus, MA 01906 Phone: 781-233-1450 |
Natasha Shah, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1069 Broadway, Saugus, MA 01906 Phone: 781-233-1450 Fax: 781-233-1100 |
Christine Valdes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1069 Broadway, Saugus, MA 01906 Phone: 781-233-1450 |
News Archive
Amid the coronavirus disease (COVID-19) outbreak, scientists from around the globe race to fight the deadly virus. Now, a team of Harvard scientists has joined forces with Chinese experts to develop new therapies and prevent the further spread of the virus.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Scientists have demonstrated a new way to investigate mechanisms at work in Alzheimer's and other neurodegenerative diseases, which also could prove useful in the search for effective drugs. For new insights, they turned to the zebrafish, which is transparent in the early stages of its life. The researchers developed a transgenic variety, the "MitoFish," that enables them to see - within individual neurons of living animals - how brain diseases disturb the transport of mitochondria, the power plants of the cell.
Sen. Olympia Snowe, R-Maine, cited the polarized climate of Congress and Washington as a key reason she will leave the Senate. Her departure renews Democrats' hope of winning this GOP seat.
Two clinical trials of an investigational drug that targets the opioid system support its safety and effectiveness in reducing symptoms of major depression, when added to standard antidepressant treatment.
› Verified 2 days ago